🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several professionals said the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Reaction and Content Removal

According to TikTok, the service has removed problematic material and prohibited related hashtags and search suggestions. The company stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Trading Operations

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.

After moments of entering one community, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Item Information and Pricing

Within these communities, messages display black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious health risks”.